2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow APR-246: new trials by email Literature Review of APR-246 trials Research Report on APR-246
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma APR-246, Dabrafenib - Melanoma | Phase 1 / Phase 2 | Terminated | Aprea Therapeutics | 3 | 2018-01-18 | 2019-07-31 |
| A Study of APR-246 in Oesophageal Cancer APR-246 - Oesophageal Carcinoma | Phase 1 / Phase 2 | Terminated | Peter MacCallum Cancer Centre, Australia | 5 | 2017-04-11 | 2021-12-13 |
Esophageal Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Skin Neoplasms (1)
Aprea Therapeutics (1) · Peter MacCallum Cancer Centre, Australia (1)
Australia (1) · Belgium (1)
Ahmad Awada, PhD (1) · Joseph Kerger, MD (1) · Lara Lipton, MB.BS FRACP (1)